Navigation Links
Amylin Pharmaceuticals Reports 2007 Financial Results
Date:1/28/2008

Net product sales increased 48% over 2006 to $701 million

SAN DIEGO, Jan. 28 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter and year ended December 31, 2007. The Company reported total revenue of $222.0 million for the quarter ended December 31, 2007, which includes net product sales of $194.7 million. Net loss was $76.9 million, or $0.57 per share for the quarter ended December 31, 2007. Net loss for the quarter ended December 31, 2007 includes a full year non-cash expense of approximately $17 million associated with the adoption of an employee stock ownership plan (ESOP). The Company reported total revenue of $781.0 million for the year ended December 31, 2007, which includes net product sales of $701.5 million. Net loss for the year ended December 31, 2007 was $211.1 million, or $1.59 per share. At December 31, 2007 the Company held cash, cash equivalents and short-term investments of approximately $1.1 billion.

"BYETTA and SYMLIN continued to experience growth in physician adoption and prescriptions, generating net product sales of over $700 million. In addition, we announced positive clinical data from our key development programs, including exenatide once weekly, BYETTA monotherapy, and our pramlintide-metreleptin obesity program," said Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmaceuticals. "For 2008, we remain confident in prospects for the continued growth of BYETTA and SYMLIN and we have aggressive development plans for the year. These plans balance investments across opportunities in the near, mid and long-term and include the completion of our Ohio manufacturing facility, a strong clinical program to expand a
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
2. Amylin Pharmaceuticals to Present at Research & Development Day
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Webcast Third Quarter Results
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
7. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
8. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
9. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
10. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... ... Trevor L. Williams, DMD holds a Bachelor of Science degree in Biomedical Sciences ... in Microbiology. He graduated from the University of Florida College of Dentistry in 2015 ... and the Academy of General Dentistry. Dr. Williams was born in Tampa and is ...
(Date:7/1/2015)... West Orange, NJ (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder ... to the National Scoliosis Foundation, it affects 2 to 3 percent of the population, or ... ages, scoliosis most often develops in children between the ages of 10 and 15. Most ...
(Date:7/1/2015)... Columbus, OH (PRWEB) , ... July 01, 2015 , ... ... pleased to announce Dr. Leslie King has been named Dean of the ... role as Dean, Dr. King will promote and support the vision and mission of ...
(Date:7/1/2015)... ... 01, 2015 , ... A Priority Setting Partnership put in ... list they hope will guide future mesothelioma research. Surviving Mesothelioma has just posted ... , More than 450 mesothelioma patients, caregivers, and healthcare professionals answer the ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Amada Senior ... a new office in the greater Phoenix area – their Mesa, Arizona location ... to senior care with their purchase of the rights to the area after years ...
Breaking Medicine News(10 mins):Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Franklin University Appoints Dean of College of Health & Public Administration 2Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Amada Senior Care Expands to Greater Phoenix Area 2
... right side, requiring colonoscopy for detection, study says , SUNDAY, May ... as women to have colon polyps and are also more likely ... found. , The researchers also found that the study patients older ... those younger than 60. , Polyps are growths in the large ...
... supports most options, but families driven by need to help, ... -- About one in five children with autism uses alternative ... special diet, a new study finds. , Of 1,212 children ... 17 percent were on special diets. More than half of ...
... ... the economy recovers and national Health Reform is implemented, explore the possible implications for ... ... BMEGateway, the national leader in Independent Evaluation and Review services for over 20 years, ...
... It is well-known that children in foster care are at increased ... who live with relatives other than their birth parents? Children ... child welfare agencies, and little research has been done on this ... MD, and her colleagues, used data from a 2007 national survey ...
... Physicians usually ask children to fast overnight before a cholesterol ... necessary. "Cholesterol testing can be very difficult for families," ... to be presented Sunday, May 2 at the Pediatric Academic ... having to fast, this almost always means the child has ...
... beyond the postpartum period and become a chronic condition, ... of Medicine. The study also finds that symptoms could ... presented May 1 by lead author Carol C. Weitzman, ... Study Center at Yale School at Yale School of ...
Cached Medicine News:Health News:Colon Polyps More Common in Hispanic Men Than Women 2Health News:Parents of Autistic Children Turning to Alternative Treatments 2Health News:Parents of Autistic Children Turning to Alternative Treatments 3Health News:Parents of Autistic Children Turning to Alternative Treatments 4Health News:BMEGateway Announces Insurance Symposium Will Focus on Orthopedic Issues with an All-star Team of Experts Held May 18, 2010 2Health News:BMEGateway Announces Insurance Symposium Will Focus on Orthopedic Issues with an All-star Team of Experts Held May 18, 2010 3Health News:Children living with relatives struggle with physical, mental health issues 2Health News:Children may be able to eat before cholesterol test, study shows 2Health News:Beyond postpartum -- treating depression in mothers of older children 2
(Date:7/1/2015)... 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... inaugural Cantor Fitzgerald Healthcare Conference on Wednesday, July 8, 2015 ... in New York . A live ... . A replay will be available approximately one hour after ...
(Date:7/1/2015)... 2015 Lupin , ... Total Number of MPP Sub-licensees to Fourteen Companies   ... announced the rapid expansion of its network of generic manufacturers ... to develop MPP-licensed antiretrovirals (ARVs). New companies Lupin and Strides ... new HIV medicine the MPP licensed from ViiV Healthcare two ...
(Date:7/1/2015)... SAN DIEGO , July 1, 2015  AVACEN, Inc. ... a second AVACEN patent covering the medical technology platform supporting ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... The apparatus and methods patent no. 9,066,781 - Methods And ... devices manufactured by AVACEN and specific methods of use, referred ...
Breaking Medicine Technology:MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3AVACEN Medical Patent Issued 2
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
... handheld oximeter has been converted to the ... now compatible with the entire line of ... Sensor and SoftCare Nonadhesive Sensors. The redesigned ... Nellcor's latest advanced signal processing technology, which ...
... expanding the growing portfolio of OxiMax® ... is a compact, affordable bedside monitor. ... processing technology, it offers reliable operation ... compatible with the complete family of ...
The Model 900 is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring. It also incorporates an LCD waveform m...
Medicine Products: